Researchers have developed a machine learning model called DreaMS, which significantly accelerates the analysis of previously unknown molecules. The study is published in Nature Biotechnology.

Rokeby brings a distinctive perspective to this exploration through his work as director of the University of Toronto’s BMO ...

Nucleome Therapeutics (‘Nucleome’ or ‘the Company’), a biotechnology company harnessing the power of non-coding human genetics to discover first-in-class antibody treatments for inflammatory diseases, ...

UK biotech Nucleome Therapeutics has appointed Bhavna Hunjan as chief business officer, a move that strengthens its ...

Biotechnology has emerged as a driving force in transforming healthcare. Over the past few decades, the integration of biology with advanced technology has led to significant breakthroughs. These ...

This year's winner of the Neuron Award for young promising scientists, Dr. Tomáš Pluskal from IOCB Prague, together with his student Roman Bushuiev ...

Fourth, talent will be the X-factor—biomanufacturing’s future turns on a specialised workforce trained at the intersection of ...

Antimicrobial-resistant (AMR) “superbugs” contribute to more than 4.5 million deaths globally per year and threaten to make ...

COMPUTEX 2025 concluded today after four days of dynamic exhibitions and events. The show welcomed an impressive turnout, with 86,521 buyers from 152 countries, including Japan, the United States, ...

Medical robotics first entered general surgery in the 1980s with laparoscopic tools that enabled minimally invasive ...

At the recent Eurovision Song Contest, the semi-finals opened with the anthem, Made in Switzerland, honouring the iconic products of the host nation. Surrounded by dancing dairy cows, the chorus ...